Mythreye Karthikeyan, PhDUniversity of South Carolina Specific targeting of Inhibin in ovarian cancers lacking the Type-III TGF-β receptor Ovarian cancer is associated with a high degree of heterogeneity (meaning the tumors differ from patient to patient), highlighting the importance of developing individualized treatment. Changes in the levels of the growth factors belonging to the Transforming […]
Read More